Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- Professor of Clinical Neurology
- Brain Repair & Rehabilitation
- Institute of Neurology
- Faculty of Brain Sciences
David is Professor of Clinical Neurology at UCL Institute of Neurology, Queen Square, and Honorary Consultant Neurologist at University College Hospital and The National Hospital, Queen Square. He trained in medicine at Guy's hospital and in neurology in London including The Maudsley Hospital, King's College Hospital, St Thomas' Hospital, and the National Hospital. Prof Werring contributes to delivering hyper-acute, acute and outpatient stroke care. He runs a specialist outpatient service for patients with cerebral small vessel disease and a one-stop intracranial haemorrhage clinic at Queen Square with same-day neuroimaging, neuropsychological assessment, specialist nurse and consultant opinions. Prof Werring is a member of the Association of British Neurologists Stroke Special Interest Group, Chair of the European Stroke Organisation Educational Committee, Deputy Secretary of the British Association of Stroke Physicians, member of the Stroke Intercollegiate Guideline Working Group and on the Editorial Board of the European Stroke Journal.
As a clinical academic I divide my time equally between clinical stroke care (at University College Hospital and The National Hospital for Neurology and Neurosurgery, Queen Square) and academic commitments at the Stroke Research Centre, UCL Institute of Neurology. My major research interest is in the clinical an pathophysiological implications of cerebral small vessel disease (the commonest known brain disorder). My focus is on intracranial (including intracerebral) haemorrhage, which is the most devastating type of stroke. I have expertise in observational studies and neuroimaging including magnetic resonance imaging (MRI). I lead a research programme including observational, genetic and neuroimaging studies of subarachnoid haemorrhage and intracerebral haemorrhage, with particular expertise in cerebral amyloid angiopathy. I am Chief Investigator for the Clinical Relevance of Microbleeds in Stroke (CROMIS-2) study: www.ucl.ac.uk/cromis-2. In collaboration with Prof Peter Rothwell (Oxford) I am Co-Chief Investigator for a randomised controlled trial of blood pressure lowering after intracerebral haemorrhage (Prevention Of Hypertensive Injury to the Brain - Intracerebral haemorrhage: PROHIBIT-ICH). I am Chief investigator for the Biomarkers in Cerebral Amyloid Angiopathy (BOCAA) at UCL. I was UK Chief investigator for a therapeutic trial of the monoclonal antibody Ponezumab in Cerebral Amyloid Angiopathy. I am Principal Investigator for numerous National Institute of Health Research (NIHR)-funded stroke research studies and am Speciality Lead for Stroke in the NIHR Clinical Research Network: North Thames. I am a member of Trial Steering Committees for NIHR multi-centre studies including TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage), RESTART (Restart or Stop Antithrombotics Randomised Trial), and LACI (Lacunar Intervention) trial.
Prof Werring supervises Stroke Medicine Clinical postgraduate trainees, and teaches widely on UCL MSc. courses. He teaches undergraduates at UCL and postgraduates nationally and internationally.
|2000||PhD||Doctor of Philosophy – Neurology||University College London|
|1992||MBBS||Bachelor of Medicine/Bachelor of Surgery – Medicine||University of London|
|1989||BSc||Bachelor of Science – Neuroscience||University of London|